Increases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease

scientific article published on 10 January 2018

Increases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2017-01916
P932PMC publication ID6276706
P698PubMed publication ID29329430

P50authorBabette S ZemelQ87885758
Robert N BaldassanoQ89270894
Michelle R DenburgQ95993929
Meena ThayuQ114398285
Lindsay M GriffinQ117265528
Rita M HerskovitzQ117265529
P2093author name stringArthur M Lee
Mark D DeBoer
Mary B Leonard
Lee A Denson
Jin Long
Kirabo Herbert
P2860cites workTNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 bindingQ28366349
Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1.Q30252705
Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutritionQ30275779
Increases in Sex Hormones during Anti-Tumor Necrosis Factor α Therapy in Adolescents with Crohn's DiseaseQ30277350
Bone Mineral Accrual Is Associated With Parathyroid Hormone and 1,25-Dihydroxyvitamin D Levels in Children and AdolescentsQ30278911
Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's DiseaseQ30300036
Changes in vitamin D-related mineral metabolism after induction with anti-tumor necrosis factor-α therapy in Crohn's diseaseQ30393774
Lean mass deficits, vitamin D status and exercise capacity in children and young adults after Fontan palliationQ30414856
Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clampQ30448178
Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unitQ32127649
DXA estimates of vertebral volumetric bone mineral density in children: potential advantages of paired posteroanterior and lateral scansQ33255198
The bone mineral density in childhood study: bone mineral content and density according to age, sex, and raceQ33274786
Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in childrenQ33526749
Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adultsQ33531394
Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood studyQ34019655
Determinants of changes in linear growth and body composition in incident pediatric Crohn's diseaseQ34023127
Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney diseaseQ34164661
Growth problems in children with IBD.Q34426164
Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.Q34450703
Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.Q35106293
Unbound (bioavailable) IGF1 enhances somatic growth.Q35232634
Insulin Resistance Negatively Influences the Muscle-Dependent IGF-1-Bone Mass Relationship in Premenarcheal GirlsQ35843439
Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methodsQ35939987
Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantationQ35966135
Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiationQ36906942
Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled TrialQ36963693
Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn diseaseQ37071224
Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactionsQ37283796
An evidence-based comparison of operational criteria for the presence of sarcopeniaQ37709589
Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitisQ40424076
Development and validation of a pediatric Crohn's disease activity indexQ40749458
Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat boneQ43917296
Infliximab reverses growth hormone resistance associated with inflammatory bowel diseaseQ59310001
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's diseaseQ63466830
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferationQ73941872
Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritisQ74631174
Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3Q78767560
Effects of Increased Muscle Mass on Bone in Male Mice Overexpressing IGF-I in Skeletal MusclesQ79180381
Validation of a self-administered instrument to assess stage of adolescent developmentQ86912908
Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official PositionsQ87580460
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectTNF inhibitorQ1536078
P304page(s)936-945
P577publication date2018-01-10
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleIncreases in IGF-1 after Anti-TNF-α Therapy are Associated with Bone and Muscle Accrual in Pediatric Crohn's Disease
P478volume103

Reverse relations

cites work (P2860)
Q99560815Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Q64080518Conceptual Model of Lean Body Mass in Pediatric Inflammatory Bowel Disease

Search more.